Cargando…

Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23–26 Weeks Gestation

The aim of this study was to investigate the relationship between survival and incidence of bronchopulmonary dysplasia (BPD) in extremely premature infants, and identify clinical factors responsible for this association. Medical records of 350 infants at 23–26 weeks gestation from 2000 to 2005 (peri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jin Kyu, Chang, Yun Sil, Sung, Sein, Ahn, So Yoon, Yoo, Hye Soo, Park, Won Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779868/ https://www.ncbi.nlm.nih.gov/pubmed/26955244 http://dx.doi.org/10.3346/jkms.2016.31.3.423

Ejemplares similares

Trends in the incidence and associated factors of late-onset sepsis associated with improved survival in extremely preterm infants born at 23–26 weeks’ gestation: a retrospective study
por: Kim, Jin Kyu, et al.
Publicado: (2018)

The Timing of Surgical Ligation for Patent Ductus Arteriosus Is Associated with Neonatal Morbidity in Extremely Preterm Infants Born at 23-25 Weeks of Gestation
por: Sung, Se In, et al.
Publicado: (2014)

Bronchopulmonary Dysplasia in Preterm Infants Born at Less Than 32 Weeks Gestation
por: Xu, Yan-Ping
Publicado: (2016)

Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation
por: Sung, Se In, et al.
Publicado: (2019)

Changes in Serum Creatinine Levels and Natural Evolution of Acute Kidney Injury with Conservative Management of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants at 23–26 Weeks of Gestation
por: Seo, Eun Seop, et al.
Publicado: (2020)

Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants
por: Kim, Hyun Ho, et al.
Publicado: (2021)

Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants
por: Jeon, Ga Won, et al.
Publicado: (2022)

Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in Korean Neonatal Network
por: Jeon, Ga Won, et al.
Publicado: (2021)

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial
por: Ahn, So Yoon, et al.
Publicado: (2021)

Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
por: Mowitz, Meredith E., et al.
Publicado: (2019)

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
por: Trittmann, J. K., et al.
Publicado: (2013)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation
por: Yang, Joo Yun, et al.
Publicado: (2014)

Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study
por: GOUYON, J.-B., et al.
Publicado: (2013)

Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
por: Chen, Wenwen, et al.
Publicado: (2021)

Stem Cell Therapy for Bronchopulmonary Dysplasia: Bench to Bedside Translation
por: Ahn, So Yoon, et al.
Publicado: (2015)

Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia
por: Madden, J, et al.
Publicado: (2010)

New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks
por: Geetha, Odattil, et al.
Publicado: (2021)

Changes in the Composition of the Gut Microbiota and the Blood Transcriptome in Preterm Infants at Less than 29 Weeks Gestation Diagnosed with Bronchopulmonary Dysplasia
por: Ryan, Feargal J., et al.
Publicado: (2019)

A prediction nomogram for moderate-to-severe bronchopulmonary dysplasia in preterm infants < 32 weeks of gestation: A multicenter retrospective study
por: Zhang, Jing, et al.
Publicado: (2023)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Vitamin D and bronchopulmonary dysplasia in preterm infants
por: Joung, K E, et al.
Publicado: (2016)

Bronchopulmonary dysplasia is associated with reduced oral nitrate reductase activity in extremely preterm infants
por: Gentle, Samuel J., et al.
Publicado: (2020)

Trends in Overall Mortality, and Timing and Cause of Death among Extremely Preterm Infants near the Limit of Viability
por: Park, Jae Hyun, et al.
Publicado: (2017)

Mortality rate-dependent variations in the survival without major morbidities rate of extremely preterm infants
por: Kim, Jin Kyu, et al.
Publicado: (2019)

Initial respiratory management in preterm infants and bronchopulmonary dysplasia
por: López, Ester Sanz, et al.
Publicado: (2011)

Association between anemia and bronchopulmonary dysplasia in preterm infants
por: Duan, Jun, et al.
Publicado: (2016)

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
por: Muehlbacher, Tobias, et al.
Publicado: (2021)

Association between probiotics and bronchopulmonary dysplasia in preterm infants
por: Qu, Yangming, et al.
Publicado: (2021)

Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)

Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants
por: Sun, Tong, et al.
Publicado: (2021)

The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
por: Xu, Yanping, et al.
Publicado: (2022)

State of the Art Review: Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants
por: Foglia, Elizabeth E., et al.
Publicado: (2017)

The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
por: Collins, Carmel T., et al.
Publicado: (2016)

Iron Supplementation and the Risk of Bronchopulmonary Dysplasia in Extremely Low Gestational Age Newborns
por: Garcia, Melissa R, et al.
Publicado: (2023)

The Youngest Survivor with Gestational Age of 21(5)/(7) Weeks
por: Sung, Se In, et al.
Publicado: (2017)

Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Enteral Feeding/Total Fluid Intake Ratio Is Associated With Risk of Bronchopulmonary Dysplasia in Extremely Preterm Infants
por: Lin, Bingchun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l3tobdm7q1aqe2l4mkc8cc0b1d